Federal inspectors found that staff at Flanagan Rehabilitation & HCC ignored their own electronic alerts and left a cognitively impaired resident without proper bowel management despite having Milk of Magnesia ordered as needed for constipation.
The resident, identified as R3 in inspection records, has taken Tramadol 50 milligrams daily since April 2023. Medical records show the patient has severe cognitive impairment and depends entirely on staff for toileting hygiene.
Bowel tracking reports from August 20 through September 18 revealed a disturbing pattern. The resident had no bowel movements for three consecutive days multiple times, including August 21-23, August 25-27, August 29 through September 1, September 3-4, and September 11-13.
On September 17 and 18, the day of inspection, the resident again had no documented bowel movements.
Staff never administered the prescribed Milk of Magnesia during this entire period, according to medication records. Nursing notes from August 15 through September 18 contain no documentation that anyone assessed the resident for constipation or offered any bowel interventions.
The facility's electronic medical system generates alerts when residents go three or more days without bowel movements. But those alerts apparently went unheeded.
"The system triggers an alert if a resident doesn't have a bowel movement for three or more days," registered nurse V4 told inspectors on September 18. She claimed the resident "has occasional constipation, but nothing frequent."
Yet the bowel tracking report contradicted her assessment, showing the resident regularly experienced multi-day periods without bowel movements.
A certified nursing assistant assigned to the resident's care that day confirmed the patient had not had a bowel movement. The aide said bowel movements "are generally soft, but R3 has constipation about once per week."
Director of Nursing V2 acknowledged the facility's failures during the inspection. She confirmed the resident's care plan completely ignored opioid use and monitoring, including the well-established risk for constipation that comes with daily Tramadol.
"The system sends an alert after three full days have passed with no BM, and continues to alert until addressed," the director explained. But she admitted staff weren't responding appropriately to those alerts.
The director reviewed the 30-day bowel tracking report during the inspection and confirmed the multiple periods without documented bowel movements. She noted that because the resident typically had a bowel movement on the fourth day, the electronic system wouldn't generate an alert.
"I would expect Milk of Magnesia to be given on day four of no BM," she told inspectors, acknowledging this wasn't happening.
When pressed about protocols, the director initially claimed the facility had a bowel protocol to follow. But after consulting with corporate staff, she reversed course.
"The facility does not have a bowel protocol; it is individually based on each resident's needs and bowel patterns," she said at 2:45 PM.
The director attempted to justify the lack of intervention by saying it would depend on whether the resident experienced symptoms like nausea, vomiting, or decreased appetite, "which R3 has not had."
This reasoning ignored the fundamental medical reality that opioids like Tramadol commonly cause constipation, requiring proactive management rather than waiting for symptoms to develop.
The resident's Minimum Data Set assessment documented severe cognitive impairment, meaning the patient couldn't advocate for themselves or communicate discomfort effectively. This made staff monitoring even more critical.
During the inspection, the director suggested she "might look into getting R3 something scheduled routinely for R3's bowels" and acknowledged the "risk of constipation with opioid use."
She also indicated she would explore changing the electronic alert system to notify staff after two days instead of three.
The violation represents a failure to provide appropriate treatment according to physician orders and the resident's medical needs. Federal regulations require nursing homes to ensure residents receive proper care for conditions that can reasonably be anticipated based on their medications and medical history.
For a resident taking daily opioids with severe cognitive impairment and complete dependence on staff for toileting, regular bowel monitoring and proactive constipation management should have been standard care.
Instead, this vulnerable resident endured repeated episodes of constipation while prescribed medication sat unused and electronic alerts went ignored.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Flanagan Rehabilitation & Hcc from 2025-09-18 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Flanagan Rehabilitation & Hcc
- Browse all IL nursing home inspections